It has been anticipated that consumption and depletion of ARG from the tumor stroma due to the overexpression of ARG2 by CAFs would be detrimental for cancer cells, which contrasts the clinical aggressiveness of tumors with high stroma ARG2 expression, as found in the current study. This evidence concerns the gene ARG2 and neoplasm.